Using coded nanoparticles, a research team has developed a method to detect and diagnose cancers.
In its current level of laboratory testing, the method has been successful in detecting multiple forms of breast cancer in mice, Xinhua news agency reported on Tuesday.
"Currently, for diagnosis of many diseases such as cancer, they rely on medical imaging but ultimately need to take tissue out for testing. We would like to move that to a different approach using optical imaging," co-author Yiqing Lu from Macquarie University in Australia said.
"This technique has the potential to provide a low-invasive method of determining if breast cancer is present, as well as the form of it, without the need to take tissue samples via biopsy," joint-lead author Fan Zhang from Fudan University added.
Light absorbing and scattering elements such as blood, muscle and cartilage produce too much interference making it difficult to determine if a range of disease biomarkers are present, suggests the study published in the journal Nature Nanotechnology.
-
Best Of NDTV World Summit 2026 | Defining Conversations, Big Ideas -
PM Modi Says 'Parasite' Congress Hurts 'Honest' Dissent Movements -
"Some Dreaming Of Disorder": PM Modi's Dig At Rahul Gandhi -
PM Modi Highlights India's Firsts: Fast Breeder Reactor, Hydrogen Train, Asian Games Medals -
"UN's Limits Clearly Visible": PM Modi Presses For 'New Solutions' At NDTV Summit -
"World That Relied On India's Brainpower Now Trusts Its Mindpower": PM Modi -
Non-Oil Trade With India Went Up 50% In 3 Years: UAE Minister At NDTV Summit -
"Some Dreaming Of Disorder": PM's "Failed Product Of Congress" Jibe At Rahul Gandhi -
'Viksit Bharat Not Just For Us': PM Modi's Top Quotes At NDTV World Summit -
Has Indian Cuisine Arrived At The Global Stage? What Vir Sanghvi Believes
The research team's solution was to engineer special nanoparticles which emit light for a set period of time.
"It is the duration of the light-emission and the biomarker reaction to this timed amount of light that produces a clearly identifiable molecular signature. This enables high-contrast optical biomedical imaging that can detect multiple disease biomarkers all at one time," Yiqing Lu said.
Track Latest News Live on NDTV.com and get news updates from India and around the world